A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design

AIMS: Androgen deprivation therapy (ADT), usually achieved with luteinising hormone releasing hormone analogues (LHRHa), is central to prostate cancer management. LHRHa reduce both testosterone and oestrogen and are associated with significant long-term toxicity. Previous use of oral oestrogens as A...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Oncol (R Coll Radiol)
Autores principales: Gilbert, D.C., Nankivell, M., Rush, H., Clarke, N.W., Mangar, S., Al-hasso, A., Rosen, S., Kockelbergh, R., Sundaram, S.K., Dixit, S., Laniado, M., McPhail, N., Shaheen, A., Brown, S., Gale, J., Deighan, J., Marshall, J., Duong, T., Macnair, A., Griffiths, A., Amos, C.L., Sydes, M.R., James, N.D., Parmar, M.K.B., Langley, R.E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2024
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7617162/
https://ncbi.nlm.nih.gov/pubmed/37973477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clon.2023.10.054
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares